Turkmenistan - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Turkmenistan Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases rose 25.4% year on year. At 649 Cases in 2019, the country was ranked number 58 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. Turkmenistan is overtaken by Moldova, which was number 57 with 655 Cases and is followed by Nepal at 635 Cases. India ranked the highest with 66,255 Cases in 2019, a growth of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 649.00 |
2018 | 549.00 |
2017 | 343.00 |
2016 | 560.00 |
2015 | 268.00 |
How does Turkmenistan rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
55 |
#55
Uganda
|
726 | 2019 | +7.2 % | +23.3 % | View data | |
58 |
#58
Turkmenistan
|
649 | 2019 | +18.2 % | +25.4 % | View data | |
59 |
#59
Nepal
|
635 | 2019 | -5.1 % | +9.4 % | View data |